Differential responses of osteoblasts and macrophages upon Staphylococcus aureus infection

BMC Microbiology

Volumn 14, Issue 1, 2014, Pages

  Hamza, Therwa ^a,b   Li, Bingyun ^a,b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Chronic infection; Infection; Internalization; Intracellular bacteria; Recurrent infection; S. aureus

Indexed keywords

ALKALINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE;

ANIMAL; BACTERIAL COUNT; CELL CULTURE; ENDOCYTOSIS; IMMUNOLOGY; MACROPHAGE; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; OSTEOBLAST; PHYSIOLOGY; RAT; STAPHYLOCOCCUS AUREUS;

ALKALINE PHOSPHATASE; ANIMALS; CELLS, CULTURED; COLONY COUNT, MICROBIAL; ENDOCYTOSIS; MACROPHAGES; MICROBIAL VIABILITY; OSTEOBLASTS; RATS; REACTIVE OXYGEN SPECIES; STAPHYLOCOCCUS AUREUS;

EID: 84905394298     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-014-0207-5     Document Type: Article

References (64)

1. Treatment of infections associated with surgical implants. RO Darouiche, N Engl J Med 2004 350 14 1422 1429 10.1056/NEJMra035415 15070792 (Pubitemid 38419996)
2. Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: A cause for antibiotic treatment failure in a patient with Darier's disease. C von Eiff, K Becker, D Metze, G Lubritz, J Hockmann, T Schwarz, G Peters, Clin Infect Dis 2001 32 11 1643 1647 10.1086/320519 (Pubitemid 32458736)
3. Prosthetic joint infections: Bane of orthopedists, challenge for infectious disease specialists. JR Lentino, Clin Infect Dis 2003 36 9 1157 1161 10.1086/374554 12715311 (Pubitemid 36549638)
4. Bone and joint infection. T Berendt, I Byren, Clin Med 2004 4 6 510 518 10.7861/clinmedicine.4-6-510 15656476 (Pubitemid 40070271)
5. Osteomyelitis. DP Lew, FA Waldvogel, Lancet 2004 364 9431 369 379 10.1016/S0140-6736(04)16727-5 15276398 (Pubitemid 38976521)
6. A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. M Kubica, K Guzik, J Koziel, M Zarebski, W Richter, B Gajkowska, A Golda, A Maciag-Gudowska, K Brix, L Shaw, T Foster, J Potempa, PLoS One 2008 3 1 1409 10.1371/journal.pone.0001409 18183290 (Pubitemid 351234509)
7. Survival of Staphylococcus aureus inside neutrophils contributes to infection. HD Gresham, JH Lowrance, TE Caver, BS Wilson, AL Cheung, FP Lindberg, J Immunol 2000 164 7 3713 3722 10.4049/jimmunol.164.7.3713 10725730 (Pubitemid 30169827)
8. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. JA Voyich, KR Braughton, DE Sturdevant, AR Whitney, B Said-Salim, SF Porcella, RD Long, DW Dorward, DJ Gardner, BN Kreiswirth, JM Musser, FR DeLeo, J Immunol 2005 175 6 3907 3919 10.4049/jimmunol.175.6.3907 16148137 (Pubitemid 41292051)
9. Phagocytosis and intracellular killing of Staphylococcus aureus by normal mouse peritoneal macrophages. R Baughn, PF Bonventre, Infect Immun 1975 12 2 346 352 807524
10. Internalization of Staphylococcus aureus by cultured osteoblasts. MC Hudson, WK Ramp, NC Nicholson, AS Williams, MT Nousiainen, Microb Pathog 1995 19 6 409 419 10.1006/mpat.1995.0075 8852281 (Pubitemid 26091044)
11. Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells. O Krut, H Sommer, M Kronke, J Antimicrob Chemother 2004 53 2 167 173 10.1093/jac/dkh076 14729736 (Pubitemid 38239945)
12. Staphylococcus aureus invasion of bovine mammary epithelial cells. RA Almeida, KR Matthews, E Cifrian, AJ Guidry, SP Oliver, J Dairy Sci 1996 79 6 1021 1026 10.3168/jds.S0022-0302(96)76454-8 8827466 (Pubitemid 126429138)
13. Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. O Vesga, MC Groeschel, MF Otten, DW Brar, JM Vann, RA Proctor, J Infect Dis 1996 173 3 739 742 10.1093/infdis/173.3.739 8627043 (Pubitemid 26064079)
14. Gentamicin-resistant menadione and hemin auxotrophic staphylococcus-aureus persist within cultured endothelial-cells. JM Balwit, P Vanlangevelde, JM Vann, RA Proctor, J Infect Dis 1994 170 4 1033 1037 10.1093/infdis/170.4.1033 7930701 (Pubitemid 24296593)
15. Staphylococcus aureus: new evidence for intracellular persistence. C Garzoni, WL Kelley, Trends Microbiol 2009 17 2 59 65 10.1016/j.tim.2008.11.005 19208480
16. Altered gene expression in Staphylococcus aureus upon interaction with human endothelial cells. AJM Vriesema, H Beekhuizen, M Hamdi, A Soufan, A Lammers, B Willekens, O Bakker, AGA Welten, MHAM Veltrop, JS van de Gevel, J Dankert, SA Zaat, Infect Immun 2000 68 4 1765 1772 10.1128/IAI.68.4.1765-1772.2000 10722562 (Pubitemid 30164797)
17. Intracellular Staphylococcus aureus and antibiotic resistance: Implications for treatment of staphylococcal osteomyelitis. JK Ellington, M Harris, MC Hudson, S Vishin, LX Webb, R Sherertz, J Orthop Res 2006 24 1 87 93 10.1002/jor.20003 16419973 (Pubitemid 43772612)
18. Nanomedicine as an emerging approach against intracellular pathogens. AL Armstead, BY Li, Int J Nanomedicine 2011 6 3281 3293 22228996
19. MJ Favus, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism American Society for Bone and Mineral Research, Washington, DC 2006
20. Staphylococcus aureus infection of mouse or human osteoblasts induces high levels of interleukin-6 and interleukin-12 production. KL Bost, WK Ramp, NC Nicholson, JL Bento, I Marriott, MC Hudson, J Infect Dis 1999 180 6 1912 1920 10.1086/315138 10558948
21. Differential regulation of chemokine secretion in tuberculous and staphylococcal osteomyelitis. KM Wright, JS Friedland, J Bone Miner Res 2002 17 9 1680 1690 10.1359/jbmr.2002.17.9.1680 12211439
22. Intracellular Staphylococcus aureus induces apoptosis in mouse osteoblasts. KA Tucker, SS Reilly, CS Leslie, MC Hudson, FEMS Microbiol Lett 2000 186 2 151 156 10.1111/j.1574-6968.2000.tb09096.x 10802163 (Pubitemid 30232734)
23. Mechanisms of Staphylococcus aureus invasion of cultured osteoblasts. JK Ellington, SS Reilly, WK Ramp, MS Smeltzer, JF Kellam, MC Hudson, Microb Pathog 1999 26 6 317 323 10.1006/mpat.1999.0272 10343060 (Pubitemid 29292118)
24. The destruction of bone by neutrophils. RA Allardyce, Y Wang, GR Rogers, WJ Gillespia, JS Doyle, Chin Med J 1995 108 9 708 709 8575240
25. A phagosome of one's own: a microbial guide to life in the macrophage. AO Amer, MS Swanson, Curr Opin Microbiol 2002 5 1 56 61 10.1016/S1369-5274(02)00286-2 11834370 (Pubitemid 34118158)
26. Streptococcus pyogenes bacteria modulate membrane traffic in human neutrophils and selectively inhibit azurophilic granule fusion with phagosomes. L Staali, S Bauer, M Morgelin, L Bjorck, H Tapper, Cell Microbiol 2006 8 4 690 703 10.1111/j.1462-5822.2005.00662.x 16548894 (Pubitemid 43372746)
27. Granulocyte apoptosis and the control of inflammation. C Haslett, JS Savill, MKB Whyte, M Stern, I Dransfield, LC Meagher, Philos T Roy Soc B 1994 345 1313 327 333 10.1098/rstb.1994.0113
28. Staphylococcus aureus bacteremia and endocarditis. CA Petti, VG Fowler, Infect Dis Clin N Am 2002 16 2 413 10.1016/S0891-5520(01)00003-4 (Pubitemid 34663644)
29. Multiple virulence factors are required for Staphylococcus aureus-induced apoptosis in endothelial cells. B Haslinger-Loffler, BC Kahl, M Grundmeier, K Strangfeld, B Wagner, U Fischer, AL Cheung, G Peters, K Schulze-Osthoff, B Sinha, Cell Microbiol 2005 7 8 1087 1097 10.1111/j.1462-5822.2005.00533.x 16008576 (Pubitemid 41030935)
30. Staphylococcus aureus alpha-toxin induces apoptosis in peripheral blood mononuclear cells: role of endogenous tumour necrosis factor-alpha and the mitochondrial death pathway. B Haslinger, K Strangfeld, G Peters, K Schulze-Osthoff, B Sinha, Cell Microbiol 2003 5 10 729 741 10.1046/j.1462-5822.2003.00317.x 12969378 (Pubitemid 37185049)
31. PSMs of hypervirulent Staphylococcus aureus act as intracellular toxins that kill infected osteoblasts. JP Rasigade, S Trouillet-Assant, T Ferry, BA Diep, A Sapin, Y Lhoste, J Ranfaing, C Badiou, Y Benito, M Bes, F Couzon, S Tigaud, G Lina, J Etienne, F Vandenesch, F Laurent, PLoS One 2013 8 5 63176 10.1371/journal.pone.0063176 23690994
32. Mechanisms of internalization of Staphylococcus aureus by cultured human osteoblasts. M Jevon, CB Guo, BC Ma, N Mordan, SP Nair, M Harris, B Henderson, G Bentley, S Meghji, Infect Immun 1999 67 5 2677 2681 10225942 (Pubitemid 29200540)
33. Staphylococcus aureus infections. FD Lowy, N Engl J Med 1998 339 8 520 532 10.1056/NEJM199808203390806 9709046 (Pubitemid 28384886)
34. Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. C von Eiff, D Bettin, RA Proctor, B Rolauffs, N Lindner, W Winkelmann, G Peters, Clin Infect Dis 1997 25 5 1250 1251 10.1086/516962 (Pubitemid 27513223)
35. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. RA Proctor, P van Langevelde, M Kristjansson, JN Maslow, RD Arbeit, Clin Infect Dis 1995 20 1 95 102 10.1093/clinids/20.1.95 7727677
36. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. L Tuchscherr, E Medina, M Hussain, W Volker, V Heitmann, S Niemann, D Holzinger, J Roth, RA Proctor, K Becker, G Peters, B Löffler, EMBO Mol Med 2011 3 3 129 141 10.1002/emmm.201000115 21268281
37. A global view of Staphylococcus aureus whole genome expression upon internalization in human epithelial cells. C Garzoni, P Francois, A Huyghe, S Couzinet, C Tapparel, Y Charbonnier, A Renzoni, S Lucchini, DP Lew, P Vaudaux, WL Kelley, J Schrenzel, BMC Genomics 2007 8 171 10.1186/1471-2164-8-171 17570841 (Pubitemid 47079269)
38. Intracellular survival of Staphylococcus aureus within cultured enterocytes. BJ Hess, MJ Henry-Stanley, EA Erickson, CJ Wells, J Surg Res 2003 114 1 42 49 10.1016/S0022-4804(03)00314-7 13678697 (Pubitemid 37108674)
39. Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus? GE Thwaites, V Gant, Nat Rev Microbiol 2011 9 3 215 222 10.1038/nrmicro2508 21297670
40. Staphylococcus aureus sortase a contributes to the trojan horse mechanism of immune defense evasion with its intrinsic resistance to Cys184 oxidation. JA Melvin, CF Murphy, LG Dubois, JW Thompson, MA Moseley, DG McCafferty, Biochem Us 2011 50 35 7591 7599 10.1021/bi200844h
41. Staphylococcal catalase protects intracellularly survived bacteria by destroying H2O2 produced by the murine peritoneal macrophages. D Das, B Bishayi, Microb Pathog 2009 47 2 57 67 10.1016/j.micpath.2009.04.012 19439176
42. Staphylococcus aureus small colony variants, electron transport and persistent infections. PJ McNamara, RA Proctor, Int J Antimicrob Ag 2000 14 2 117 122 10.1016/S0924-8579(99)00170-3 (Pubitemid 30138178)
43. Biomaterial-associated persistence of Staphylococcus epidermidis in pericatheter macrophages. JJ Boelens, J Dankert, JL Murk, JJ Weening, T van der Poll, KP Dingemans, L Koole, JD Laman, SA Zaat, J Infect Dis 2000 181 4 1337 1349 10.1086/315369 10762565 (Pubitemid 30252538)
44. Staphylococcus epidermidis is cleared from biomaterial implants but persists in peri-implant tissue in mice despite rifampicin/vancomycin treatment. CAN Broekhuizen, L de Boer, K Schipper, CD Jones, S Quadir, CMJE Vandenbroucke-Grauls, SAJ Zaat, J Biomed Mater Res A 2008 85A 2 498 505 10.1002/jbm.a.31528 (Pubitemid 351535332)
45. Staphylococcus aureus-induced tumor necrosis factor-related apoptosis-inducing ligand expression mediates apoptosis and caspase-8 activation in infected osteoblasts. EH Alexander, IM Rivera FA, J Anguita, KL Bost, MC Hudson, BMC Microbiol 2003 3 5 10.1186/1471-2180-3-5 12697056
46. Osteoblasts produce monocyte chemoattractant protein-1 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue. I Marriott, DL Gray, DM Rati, VG Fowler, ME Stryjewski, LS Levin, MC Hudson, KL Bost, Bone 2005 37 4 504 512 10.1016/j.bone.2005.05.011 16027056 (Pubitemid 41317324)
47. Staphylococcus aureus induces expression of receptor activator of NF-kappaB ligand and prostaglandin E2 in infected murine osteoblasts. SN Somayaji, S Ritchie, M Sahraei, I Marriott, MC Hudson, Infect Immun 2008 76 11 5120 5126 10.1128/IAI.00228-08 18765718
48. Additive effects of exogenous IL-12 supplementation and antibiotic treatment in infection prophylaxis. BM Boyce, BA Lindsey, NB Clovis, ES Smith, GR Hobbs, DF Hubbard, SE Emery, JB Barnett, B Li, J Orthop Res 2012 30 2 196 202 10.1002/jor.21520 21815205
49. Cefazolin embedded biodegradable polypeptide nanofilms promising for infection prevention: a preliminary study on cell responses. HS Li, H Ogle, BB Jiang, M Hagar, BY Li, J Orthop Res 2010 28 8 992 999 20162715
50. Evaluation of local MCP-1 and IL-12 nanocoatings for infection prevention in open fractures. B Li, B Jiang, MJ Dietz, ES Smith, NB Clovis, KM Rao, J Orthop Res 2010 28 1 48 54 19588527
51. Multilayer polypeptide nanoscale coatings incorporating IL-12 for the prevention of biomedical device-associated infections. B Li, B Jiang, BM Boyce, BA Lindsey, Biomaterials 2009 30 13 2552 2558 10.1016/j.biomaterials.2009.01.042 19215980
52. Polypeptide nanocoatings for preventing dental and orthopaedic device-associated infection: pH-induced antibiotic capture, release, and antibiotic efficacy. BB Jiang, BY Li, J Biomed Mater Res B 2009 88B 2 332 338 10.1002/jbm.b.31021
53. Cationic Antimicrobial Peptide LL-37 Is Effective against both Extra- and Intracellular Staphylococcus aureus. J Noore, A Noore, BY Li, Antimicrob Agents Chemother 2013 57 3 1283 1290 10.1128/AAC.01650-12 23274662
54. Intra-cellular Staphylococcus aureus alone causes infection in vivo. T Hamza, M Dietz, D Pham, N Clovis, S Danley, B Li, Eur Cell Mater 2013 25 341 350 discussion 350 23832687
55. Effects of opsonization and gamma interferon on growth of Brucella melitensis 16 M in mouse peritoneal macrophages in vitro. MO Eze, L Yuan, RM Crawford, CM Paranavitana, TL Hadfield, AK Bhattacharjee, RL Warren, DL Hoover, Infect Immun 2000 68 1 257 263 10.1128/IAI.68.1.257-263.2000 10603396 (Pubitemid 30016705)
56. Intracellular antimicrobial activity appearing as a relevant factor in antibiotic efficacy against an experimental foreign-body infection caused by Staphylococcus aureus. O Murillo, ME Pachon, G Euba, R Verdaguer, M Carreras, C Cabellos, J Cabo, F Guidiol, J Ariza, J Antimicrob Chemoth 2009 64 5 1062 1066 10.1093/jac/dkp326
57. Biomimetic nanocoating promotes osteoblast cell adhesion on biomedical implants. F Likibi, BB Jiang, BY Li, J Mater Res 2008 23 12 3222 3228 10.1557/JMR.2008.0390
58. Use of lysostaphin to remove cell-adherent staphylococci during in vitro assays of phagocyte function. C Easmon, H Lanyon, P Cole, Br J Exp Pathol 1978 59 4 381 708586
59. Use of aminoglycosides in treatment of infections due to intracellular bacteria. M Maurin, D Raoult, Antimicrob Agents Chemother 2001 45 11 2977 2986 10.1128/AAC.45.11.2977-2986.2001 11600345 (Pubitemid 32988817)
60. Lysostaphin: an antistaphylococcal agent. JK Kumar, Appl Microbiol Biotechnol 2008 80 4 555 561 10.1007/s00253-008-1579-y 18607587
61. Double immunofluorescence microscopic technique for accurate differentiation of extracellularly and intracellularly located bacteria in cell-culture. J Heesemann, R Laufs, J Clin Microbiol 1985 22 2 168 175 3897263 (Pubitemid 15006948)
62. Microscopic quantification of bacterial invasion by a novel antibody-independent staining method. F Agerer, S Waeckerle, CR Hauck, J Microbiol Meth 2004 59 1 23 32 10.1016/j.mimet.2004.05.008 (Pubitemid 39119910)
63. Unique antimicrobial effects of platelet-rich plasma and its efficacy as a prophylaxis to prevent implant-associated spinal infection. H Li, T Hamza, JE Tidwell, N Clovis, B Li, Adv Healthcare Mater 2013 2 9 1277 1284 10.1002/adhm.201200465
64. Flow cytometric studies of oxidative product formation by neutrophils-a graded response to membrane stimulation. DA Bass, JW Parce, LR Dechatelet, P Szejda, MC Seeds, M Thomas, J Immunol 1983 130 4 1910 1917 6833755 (Pubitemid 13091657)